134 related articles for article (PubMed ID: 10850353)
1. Imaging tumor folate receptors using 111In-DTPA-methotrexate.
Ilgan S; Yang DJ; Higuchi T; Zareneyrizi F; Kim EE; Podoloff DA
Cancer Biother Radiopharm; 1998 Jun; 13(3):177-84. PubMed ID: 10850353
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-ethylenedicysteine-folate: a new tumor imaging agent. Synthesis, labeling and evaluation in animals.
Ilgan S; Yang DJ; Higuchi T; Zareneyrizi F; Bayhan H; Yu D; Kim EE; Podoloff DA
Cancer Biother Radiopharm; 1998 Dec; 13(6):427-35. PubMed ID: 10851435
[TBL] [Abstract][Full Text] [Related]
3. Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancer.
Müller C; Schibli R; Krenning EP; de Jong M
J Nucl Med; 2008 Apr; 49(4):623-9. PubMed ID: 18344429
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution and scintigraphy of [111In]DTPA-adriamycin in mammary tumor-bearing rats.
Higuchi T; Yang DJ; Ilgan S; Tansey LW; Zareneyrizi F; Inoue T; Endo K; Kim EE; Podoloff DA
Anticancer Drugs; 1999 Jan; 10(1):89-95. PubMed ID: 10194551
[TBL] [Abstract][Full Text] [Related]
5. Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical.
Mathias CJ; Wang S; Waters DJ; Turek JJ; Low PS; Green MA
J Nucl Med; 1998 Sep; 39(9):1579-85. PubMed ID: 9744347
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of [111In]DTPA-folate for use as a tumor-targeted radiopharmaceutical.
Wang S; Luo J; Lantrip DA; Waters DJ; Mathias CJ; Green MA; Fuchs PL; Low PS
Bioconjug Chem; 1997; 8(5):673-9. PubMed ID: 9327130
[TBL] [Abstract][Full Text] [Related]
7. Targeting the tumor-associated folate receptor with an 111In-DTPA conjugate of pteroic acid.
Ke CY; Mathias CJ; Green MA
J Am Chem Soc; 2005 May; 127(20):7421-6. PubMed ID: 15898791
[TBL] [Abstract][Full Text] [Related]
8. Delivery of radionuclides to pretargeted monoclonal antibodies using dihydrofolate reductase and methotrexate in an affinity system.
Hawkins GA; McCabe RP; Kim CH; Subramanian R; Bredehorst R; McCullers GA; Vogel CW; Hanna MG; Pomato N
Cancer Res; 1993 May; 53(10 Suppl):2368-73. PubMed ID: 8485723
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results.
Siegel BA; Dehdashti F; Mutch DG; Podoloff DA; Wendt R; Sutton GP; Burt RW; Ellis PR; Mathias CJ; Green MA; Gershenson DM
J Nucl Med; 2003 May; 44(5):700-7. PubMed ID: 12732670
[TBL] [Abstract][Full Text] [Related]
10. A kit formulation for preparation of [(111)In]In-DTPA-folate, a folate-receptor-targeted radiopharmaceutical.
Mathias CJ; Green MA
Nucl Med Biol; 1998 Aug; 25(6):585-7. PubMed ID: 9751427
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of methotrexate-albumin conjugates in tumor-bearing rats.
Stehle G; Wunder A; Sinn H; Schrenk HH; Schütt S; Frei E; Hartung G; Maier-Borst W; Heene DL
Anticancer Drugs; 1997 Oct; 8(9):835-44. PubMed ID: 9402310
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biodistribution and imaging properties of indium-111-DTPA-paclitaxel in mice bearing mammary tumors.
Li C; Yu DF; Inoue T; Yang DJ; Tansey W; Liu CW; Milas L; Hunter NR; Kim EE; Wallace S
J Nucl Med; 1997 Jul; 38(7):1042-7. PubMed ID: 9225788
[TBL] [Abstract][Full Text] [Related]
13. Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.
de Visser M; Janssen PJ; Srinivasan A; Reubi JC; Waser B; Erion JL; Schmidt MA; Krenning EP; de Jong M
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1134-9. PubMed ID: 12768332
[TBL] [Abstract][Full Text] [Related]
14. Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance.
Jansen G; Westerhof GR; Kathmann I; Rademaker BC; Rijksen G; Schornagel JH
Cancer Res; 1989 May; 49(9):2455-9. PubMed ID: 2706633
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biodistribution, and estrogen receptor scintigraphy of indium-111-diethylenetriaminepentaacetic acid-tamoxifen analogue.
Delpassand ES; Yang DJ; Wallace S; Cherif A; Quadri SM; Price J; Joubert A; Inoue T; Podoloff DA
J Pharm Sci; 1996 Jun; 85(6):553-9. PubMed ID: 8773948
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo studies of substance P receptor expression in rats with the new analog [indium-111-DTPA-Arg1]substance P.
Breeman WA; VanHagen MP; Visser-Wisselaar HA; van der Pluijm ME; Koper JW; Setyono-Han B; Bakker WH; Kwekkeboom DJ; Hazenberg MP; Lamberts SW; Visser TJ; Krenning EP
J Nucl Med; 1996 Jan; 37(1):108-17. PubMed ID: 8543978
[TBL] [Abstract][Full Text] [Related]
17. The loading rate determines tumor targeting properties of methotrexate-albumin conjugates in rats.
Stehle G; Sinn H; Wunder A; Schrenk HH; Schütt S; Maier-Borst W; Heene DL
Anticancer Drugs; 1997 Aug; 8(7):677-85. PubMed ID: 9311444
[TBL] [Abstract][Full Text] [Related]
18. Comparative biodistribution of potential anti-glioblastoma conjugates [111In]DTPA-hEGF and [111In]Bz-DTPA-hEGF in normal mice.
Tolmachev V; Orlova A; Wei Q; Bruskin A; Carlsson J; Gedda L
Cancer Biother Radiopharm; 2004 Aug; 19(4):491-501. PubMed ID: 15453964
[TBL] [Abstract][Full Text] [Related]
19. Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003.
Smith-Jones PM; Pandit-Taskar N; Cao W; O'Donoghue J; Philips MD; Carrasquillo J; Konner JA; Old LJ; Larson SM
Nucl Med Biol; 2008 Apr; 35(3):343-51. PubMed ID: 18355690
[TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro and in vivo evaluation of technetium-99m-labeled folate and methotrexate conjugates as tumor imaging agents.
Okarvi SM; Jammaz IA
Cancer Biother Radiopharm; 2006 Feb; 21(1):49-60. PubMed ID: 16480331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
